IN2013MU01113A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01113A
IN2013MU01113A IN1113MU2013A IN2013MU01113A IN 2013MU01113 A IN2013MU01113 A IN 2013MU01113A IN 1113MU2013 A IN1113MU2013 A IN 1113MU2013A IN 2013MU01113 A IN2013MU01113 A IN 2013MU01113A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
relates
present
Prior art date
Application number
Inventor
Prabhakar Keshav Shrikant
Shashikant Bhise Sanjay
Harishchandra Kamble Hemant
Chaudhari Ganesh
Subhash Patil Deepak
Reddy Sanikommu Srinivas
Hari Bhushan Kumar
Bhaskar Bhirud Shekhar
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Priority to PCT/IB2014/060028 priority Critical patent/WO2014155259A2/en
Priority to IN1113MU2013 priority patent/IN2013MU01113A/en
Priority to US14/780,138 priority patent/US9663505B2/en
Publication of IN2013MU01113A publication Critical patent/IN2013MU01113A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention relates to process for the preparation of rivaroxaban.
IN1113MU2013 2013-03-25 2014-03-21 IN2013MU01113A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/IB2014/060028 WO2014155259A2 (en) 2013-03-25 2014-03-21 Process for the preparation of rivaroxaban
IN1113MU2013 IN2013MU01113A (en) 2013-03-25 2014-03-21
US14/780,138 US9663505B2 (en) 2013-03-25 2014-03-21 Process for the preparation of rivaroxaban

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1113MU2013 IN2013MU01113A (en) 2013-03-25 2014-03-21

Publications (1)

Publication Number Publication Date
IN2013MU01113A true IN2013MU01113A (en) 2015-06-19

Family

ID=51625556

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1113MU2013 IN2013MU01113A (en) 2013-03-25 2014-03-21

Country Status (3)

Country Link
US (1) US9663505B2 (en)
IN (1) IN2013MU01113A (en)
WO (1) WO2014155259A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109553611A (en) * 2017-09-23 2019-04-02 齐鲁制药有限公司 The preparation method and purposes of Rivaroxaban intermediate
CN111699184B (en) * 2018-02-26 2023-05-23 住友化学株式会社 Process for producing oxazolidinone compound
CN108546265A (en) * 2018-06-22 2018-09-18 苏州中联化学制药有限公司 A kind of synthetic method of Rivaroxaban intermediate
CN114105970A (en) * 2022-01-05 2022-03-01 安徽悦康凯悦制药有限公司 Preparation method of rivaroxaban

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
DE10342570A1 (en) 2003-09-15 2005-04-14 Bayer Healthcare Ag Process for the preparation of 4- (4-aminophenyl) -3-morpholinone
DE102004002044A1 (en) 2004-01-15 2005-08-04 Bayer Healthcare Ag manufacturing
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
ES2905760T3 (en) * 2009-07-31 2022-04-12 Krka D D Novo Mesto Procedures for the crystallization of rivaroxaban
EP2521723A1 (en) 2010-01-04 2012-11-14 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
EP2388260A1 (en) 2010-05-21 2011-11-23 Archimica GmbH Method for producing a blood coagulation factor inhibitor
US20130253187A1 (en) * 2010-09-14 2013-09-26 Medichem, S.A. Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative
AU2010362639B2 (en) 2010-10-18 2016-10-27 Apotex Pharmachem Inc. Processes for the preparation of Rivaroxaban and intermediates thereof
ES2395304B1 (en) 2011-05-20 2014-01-16 Interquim, S.A. PROCEDURE FOR OBTAINING A THIOPHEN-2-CARBOXAMIDE.
CN102250076A (en) 2011-05-27 2011-11-23 横店集团家园化工有限公司 Preparation method for rivaroxaban intermediate and rivaroxaban
CN102250077B (en) * 2011-06-15 2013-11-13 浙江工业大学 Rivaroxaban intermediate and method for synthesizing rivaroxaban by same
WO2013121436A2 (en) 2012-02-06 2013-08-22 Megafine Pharma (P) Ltd A process for preparation of rivaroxaban and intermediates thereof

Also Published As

Publication number Publication date
WO2014155259A2 (en) 2014-10-02
WO2014155259A3 (en) 2015-01-29
US20160052919A1 (en) 2016-02-25
US9663505B2 (en) 2017-05-30

Similar Documents

Publication Publication Date Title
MX2015016535A (en) Production method for tagatose.
TW201613853A (en) Synthesis of polycyclic-carbamoylpyridone compounds
MX370649B (en) Process for the preparation of teneligliptin.
IN2013MU00848A (en)
MX345926B (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
MX2015007518A (en) Methods for treating pruritus.
IN2013MU00646A (en)
IN2014DN09450A (en)
IN2013MU03641A (en)
IN2014MU00455A (en)
IN2014DN08777A (en)
IN2013MU03070A (en)
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2014CH00151A (en)
IN2013MU01113A (en)
IN2014CH00304A (en)
IN2014DN10209A (en)
HUE040536T2 (en) Process for the preparation of halogen-n, n-dimethylbenzylamines
WO2014118606A3 (en) A novel process for the preparation of silodosin
IN2013MU01290A (en)
PL2883461T3 (en) Process for producing active follistatin
MX2015011881A (en) Process for the preparation of 3,7-dimethylnonan-1-ol.
MX2016002198A (en) Process for preparing a compound.
IN2013MU01219A (en)
IN2013MU03768A (en)